ZFIN ID: ZDB-FISH-150901-19358
Fish name: aldh1a2i26/i26
Genotype: aldh1a2i26/i26
Targeting Reagent: none
HUMAN DISEASE MODELED by aldh1a2i26/i26
No data available
GENE EXPRESSION
Gene expression in aldh1a2i26/i26
RNA expression
Expressed Gene Structure Conditions Figures
alcama standard conditions Fig. 5 with imageFig. 6 with image from Begemann et al., 2001
aldh1a2 standard conditions Fig. 4 with image from Begemann et al., 2001
cpa5 standard conditions Fig. 4 with image from Alexa et al., 2009
dhrs3a standard conditions Fig. 5 with image from Feng et al., 2010
dlx2a standard conditions Fig. 5 with image from Begemann et al., 2001
efnb2a standard conditions Fig. 6 with image from Begemann et al., 2001
egr2b standard conditions Fig. 1 with imageFig. 3 with imageFig. 4 with image from Begemann et al., 2001
chemical treatment: all-trans-retinoic acid Fig. 3 with image from Begemann et al., 2001
fabp2 standard conditions Fig. 4 with image from Alexa et al., 2009
gata3 standard conditions Fig. 5 with image from Wingert et al., 2011
her1 standard conditions Fig. 1 with image from Begemann et al., 2001
hhex standard conditions Fig. 3 with image from Alexa et al., 2009
hoxb3a standard conditions Fig. 6 with image from Begemann et al., 2001
hoxb4a standard conditions Fig. 6 with image from Begemann et al., 2001
hoxc6a standard conditions Fig. 1 with image from Begemann et al., 2001
ins standard conditions Fig. 3 with image from Alexa et al., 2009
Fig. 3 with image from Stetsyuk et al., 2007
kcnip3b standard conditions Fig. 3 with image from Stetsyuk et al., 2007
mafba standard conditions Fig. 6 with image from Begemann et al., 2001
mbpa standard conditions Fig. 5 with imageFig. 6 with image from Kazakova et al., 2006
chemical treatment: all-trans-retinoic acid Fig. 6 with image from Kazakova et al., 2006
myod1 standard conditions Fig. 1 with imageFig. 3 with image from Begemann et al., 2001
chemical treatment: all-trans-retinoic acid Fig. 3 with image from Begemann et al., 2001
pax2a standard conditions Fig. 1 with image from Begemann et al., 2001
pdx1 standard conditions Fig. 3 with imageFig. 4 with image from Alexa et al., 2009
plp1b standard conditions Fig. 5 with image from Kazakova et al., 2006
prox1a standard conditions Fig. 3 with image from Alexa et al., 2009
ptf1a standard conditions text only from Alexa et al., 2009
raraa standard conditions Fig. 7 with image from Linville et al., 2009
Fig. 6 with image from Begemann et al., 2001
rarab standard conditions Fig. 7 with image from Linville et al., 2009
rarga standard conditions Fig. 7 with image from Linville et al., 2009
shha standard conditions Fig. 3 with image from Begemann et al., 2001
sid4 standard conditions Fig. 4 with image from Alexa et al., 2009
slc12a1 standard conditions Fig. 5 with image from Wingert et al., 2011
slc12a3 standard conditions Fig. 5 with image from Wingert et al., 2011
slc20a1a standard conditions Fig. 5 with image from Wingert et al., 2011
sox10 standard conditions Fig. 6 with image from Kazakova et al., 2006
sst1.1 standard conditions text only from Alexa et al., 2009
tbx2b standard conditions Fig. 6 with image from Begemann et al., 2001
tbx5a standard conditions Fig. 5 with image from Linville et al., 2009
Fig. 3 with image from Begemann et al., 2001
chemical treatment: all-trans-retinoic acid Fig. 3 with image from Begemann et al., 2001
tbxta standard conditions Fig. 1 with image from Begemann et al., 2001
tfa standard conditions Fig. 4 with image from Alexa et al., 2009
trpm7 standard conditions Fig. 5 with image from Wingert et al., 2011
wt1a standard conditions Fig. 5 from Cheng et al., 2014
wt1b standard conditions Fig. 5 with image from Wingert et al., 2011
Protein expression
Antibody Antigen Genes Structure Conditions Figures
zn-8 alcama standard conditions Fig. 5 with imageFig. 6 with image from Begemann et al., 2001
Ab1-ta tbxta standard conditions Fig. 1 with image from Begemann et al., 2001
Reporter gene expression No data available
PHENOTYPE
Phenotype in aldh1a2i26/i26
Phenotype Conditions Figures
axial mesoderm development decreased process quality, abnormal standard conditions Fig. 1 with image from Begemann et al., 2001
axonogenesis involved in innervation decreased process quality, abnormal standard conditions Fig. 5 with image from Kazakova et al., 2006
digestive tract development disrupted, abnormal standard conditions text only from Nadauld et al., 2005
embryonic pectoral fin morphogenesis decreased process quality, abnormal standard conditions Fig. 1 with imageFig. 3 with image from Begemann et al., 2001
embryonic pectoral fin morphogenesis process quality, normal chemical treatment: all-trans-retinoic acid Fig. 3 with image from Begemann et al., 2001
head increased size, abnormal standard conditions Fig. 4 with image from D'Aniello et al., 2015
head misaligned with trunk, abnormal standard conditions Fig. 4 with image from Wingert et al., 2011
head notochord has fewer parts of type notochord cell, abnormal standard conditions Fig. 1 with image from Begemann et al., 2001
hindbrain posterior region physical object quality, abnormal standard conditions Fig. 6 with image from Begemann et al., 2001
hindbrain morphogenesis process quality, abnormal standard conditions Fig. 6 with image from Begemann et al., 2001
hyohyoideus decreased length, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
hyosymplectic cartilage decreased size, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
intermandibularis decreased length, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
intestinal bulb hypoplastic, abnormal standard conditions text only from Nadauld et al., 2005
intestinal epithelium aplastic, abnormal standard conditions text only from Nadauld et al., 2005
intestine lacks all parts of type columnar/cuboidal epithelial cell, abnormal standard conditions text only from Nadauld et al., 2005
intestine lacks all parts of type intestinal villus, abnormal standard conditions text only from Nadauld et al., 2005
intestine morphology, abnormal standard conditions text only from Nadauld et al., 2005
lateral plate mesoderm physical object quality, abnormal standard conditions Fig. 4 with image from Begemann et al., 2001
Meckel's cartilage decreased size, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
nervous system wholly anterioralized, abnormal standard conditions Fig. 4 with image from D'Aniello et al., 2015
notochord anterior region apoptotic, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
otic vesicle decreased distance somite 1, abnormal standard conditions Fig. 4 with image from Wingert et al., 2011
Fig. 1 with image from Begemann et al., 2001
palatoquadrate cartilage decreased size, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
paraxial mesoderm development decreased process quality, abnormal standard conditions Fig. 1 with imageFig. 3 with image from Begemann et al., 2001
paraxial mesoderm development process quality, abnormal standard conditions Fig. 4 with image from Begemann et al., 2001
paraxial mesoderm development process quality, normal chemical treatment: all-trans-retinoic acid Fig. 3 with image from Begemann et al., 2001
pectoral fin absent, abnormal heat shock Fig. 6 with image from Cunningham et al., 2013
pectoral fin aplastic, abnormal standard conditions Fig. 1 with image from Alexa et al., 2009
Fig. 5 with image from Linville et al., 2009
pectoral fin bud aplastic, abnormal standard conditions Fig. 5 with image from Linville et al., 2009
pectoral fin bud physical object quality, abnormal standard conditions Fig. 3 with image from Begemann et al., 2001
pectoral fin bud physical object quality, normal chemical treatment: all-trans-retinoic acid Fig. 3 with image from Begemann et al., 2001
pectoral fin field physical object quality, abnormal standard conditions Fig. 3 with image from Begemann et al., 2001
pericardium edematous, abnormal standard conditions Fig. 4 with image from D'Aniello et al., 2015
Fig. 4 with image from Wingert et al., 2011
Fig. 1 with image from Alexa et al., 2009
pharyngeal arch 3-7 neural crest apoptotic, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
posterior lateral line nerve dendrite unbranched, abnormal standard conditions Fig. 5 with image from Kazakova et al., 2006
posterior lateral line nerve development process quality, abnormal standard conditions Fig. 5 with image from Kazakova et al., 2006
pronephric duct distal region increased length, abnormal standard conditions Fig. 5 with image from Wingert et al., 2011
pronephric duct proximal region decreased length, abnormal standard conditions Fig. 5 with image from Wingert et al., 2011
pronephric podocyte decreased amount, abnormal standard conditions Fig. 5 from Cheng et al., 2014
rhombomere 5 decreased distance somite 1, abnormal standard conditions Fig. 1 with imageFig. 3 with image from Begemann et al., 2001
rhombomere 5 distance somite 1, normal chemical treatment: all-trans-retinoic acid Fig. 3 with image from Begemann et al., 2001
rhombomere 5 increased length, abnormal standard conditions Fig. 6 with image from Begemann et al., 2001
rhombomere 6 increased length, abnormal standard conditions Fig. 6 with image from Begemann et al., 2001
rhombomere 7 increased length, abnormal standard conditions Fig. 6 with image from Begemann et al., 2001
rhombomere 7 physical object quality, abnormal standard conditions Fig. 6 with image from Begemann et al., 2001
somite 1 fused with somite 2, abnormal standard conditions Fig. 1 with image from Begemann et al., 2001
spinal cord molecular quality, abnormal standard conditions Fig. 6 with image from Kazakova et al., 2006
spinal cord anterior region has fewer parts of type motor neuron, abnormal standard conditions Fig. 6 with image from Begemann et al., 2001
spinal cord anterior region has fewer parts of type spinal cord interneuron, abnormal standard conditions Fig. 6 with image from Begemann et al., 2001
sternohyoid decreased length, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
vertebral column anterior region decreased length, abnormal standard conditions Fig. 4 with image from Wingert et al., 2011
whole organism decreased length, abnormal standard conditions Fig. 4 with image from D'Aniello et al., 2015
whole organism lacks all parts of type pharyngeal pouch 4, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
whole organism lacks all parts of type ceratobranchial 3 cartilage, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
whole organism lacks all parts of type pectoral fin cartilage, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
whole organism lacks all parts of type ceratobranchial 5 cartilage, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
whole organism lacks all parts of type ceratobranchial 2 cartilage, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
whole organism lacks all parts of type ceratobranchial 4 cartilage, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001
whole organism lacks all parts of type pectoral fin, abnormal standard conditions Fig. 1 with image from Begemann et al., 2001
whole organism lacks all parts of type pharyngeal pouch 3, abnormal standard conditions Fig. 5 with image from Begemann et al., 2001

CITATIONS  (20)